How we use venetoclax with hypomethylating agents
由 BA Jonas 著作 · 2019 · 被引用 65 次 — Specifically, our approach to TLS monitoring involves a rapid (relative to CLL) intra-patient dose escalation protocol in which venetoclax is ... ,由 BA Jonas 著作 · 2019 · 被引用 65 次 — Acute myeloid leukemia (AML) is associated with poor outcomes, especially in older patients in whom the disease is most common. B-cell lymphoma 2 (BCL-2) is ...,How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia. October 2019; Leukemia 33(12). DOI: ... ,How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia. Jonas, Brian A; Pollyea, ... ,Acute myeloid leukemia (AML) is associated with poor outcomes, especially in older patients in whom the disease is most common. B-cell lymphoma 2 (BCL-2) is ...,How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia. ABSTRACT.
| 相關軟體 HMA! Pro VPN 資訊 | |
|---|---|
 How we use venetoclax with hypomethylating agents 相關參考資料
How we use venetoclax with hypomethylating agents ... - Nature
由 BA Jonas 著作 · 2019 · 被引用 65 次 — Specifically, our approach to TLS monitoring involves a rapid (relative to CLL) intra-patient dose escalation protocol in which venetoclax is ... https://www.nature.com How we use venetoclax with hypomethylating ... - PubMed
由 BA Jonas 著作 · 2019 · 被引用 65 次 — Acute myeloid leukemia (AML) is associated with poor outcomes, especially in older patients in whom the disease is most common. B-cell lymphoma 2 (BCL-2) is ... https://pubmed.ncbi.nlm.nih.go (PDF) How we use venetoclax with hypomethylating agents ...
How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia. October 2019; Leukemia 33(12). DOI: ... https://www.researchgate.net How we use venetoclax with hypomethylating agents - ProQuest
How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia. Jonas, Brian A; Pollyea, ... https://www.proquest.com How we use venetoclax with hypomethylating agents for the ...
Acute myeloid leukemia (AML) is associated with poor outcomes, especially in older patients in whom the disease is most common. B-cell lymphoma 2 (BCL-2) is ... https://www.semanticscholar.or How we use venetoclax with hypomethylating ... - theMednet
How we use venetoclax with hypomethylating agents for the treatment of newly diagnosed patients with acute myeloid leukemia. ABSTRACT. https://www.themednet.org |